The recent news has many investors reaching for answers. I myself have many unanswered thoughts of our future here. I honestly believe that the current news was the best news we have heard this year. The working with PWC is going to be very positive for BRWC and shareholders. Many have speculated a RS and I can tell you from my experience that is not going to happen here. We the long investors, the majority have faced many challenges from others that can not see the vision here. Water is a commodity and becoming scarce for pristine water such as Boreal owns and has the ability to supply World Wide in Thousands of Millions of Gallons. The play here is not this week or next or even next month. This investment is a LONG investment. My thoughts are we will see great news coming forward in the next few weeks and again and again soon after. I expect the PPS to be out of the trips by mid year and nearing half penny by the fall. This time next year this could easily be at least a penny if not multiple. BRWC is a real company with a real product with real demand. I wish all investors the best as I am a fellow shareholder with Hundreds of Millions of shares. Stay strong and hold long. BRWC
The recent news has many investors reaching for answers. I
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Concerns Rise Over Trump's Cryptocurrency Reserve Strategy
Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...
Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments
BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...
Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds
Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...
Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics
Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...
Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study
Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...
Continue Reading